Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OZANIMOD vs PANCRELIPASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OZANIMOD vs PANCRELIPASE: Safety Overview

Metric OZANIMOD PANCRELIPASE
Total FAERS Reports 7,894 724
Deaths Reported 85 66
Death Rate 1.1% 9.1%
Hospitalizations 702 281
Average Patient Age 48.8 yrs 52.0 yrs
% Female Patients 69.9% 50.4%
FDA Approval Date Mar 25, 2020 N/A
Manufacturer Celgene Corporation N/A
Route ORAL N/A
Marketing Status Prescription Discontinued